The effect of DMF in FRDA has been evaluated in lymphoblasts isolated from the YG8R mouse model and in DMF-treated lymphocytes derived from FRDA patients, showing that DMF increases FXN mRNA levels by 93% in FRDA lymphoblasts and by 52% in mice in vivo. This evidence concerns the gene FXN and Friedreich ataxia.